Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of ADAM9 mRNA | affects expression | 21346803
|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in increased expression of ADAM9 mRNA | increases expression | 18648102
|
D013196 |
Dihydrotestosterone |
AR protein affects the reaction [Dihydrotestosterone results in increased expression of ADAM9 protein] | affects reaction|increases expression | 17342749
|
D013196 |
Dihydrotestosterone |
bicalutamide inhibits the reaction [Dihydrotestosterone results in increased expression of ADAM9 protein] | decreases reaction|increases expression | 17342749
|
C041524 |
aluminum sulfate |
aluminum sulfate results in decreased expression of ADAM9 mRNA | decreases expression | 15961160
|
C053541 |
bicalutamide |
bicalutamide inhibits the reaction [Dihydrotestosterone results in increased expression of ADAM9 protein] | decreases reaction|increases expression | 17342749
|
D003513 |
Cycloheximide |
Cycloheximide inhibits the reaction [Hydrogen Peroxide results in increased expression of ADAM9 protein] | decreases reaction|increases expression | 17018608
|
D003609 |
Dactinomycin |
Dactinomycin inhibits the reaction [Hydrogen Peroxide results in increased expression of ADAM9 protein] | decreases reaction|increases expression | 17018608
|
C042986 |
ebselen |
ebselen inhibits the reaction [Hydrogen Peroxide results in increased expression of ADAM9 protein] | decreases reaction|increases expression | 17018608
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of ADAM9 mRNA | affects expression | 17555576
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of ADAM9 mRNA | increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ADAM9 mRNA | affects cotreatment|increases expression | 17942748
|
D019833 |
Genistein |
Genistein results in decreased expression of ADAM9 mRNA | decreases expression | 16169203
|
D006861 |
Hydrogen Peroxide |
CAT protein inhibits the reaction [Hydrogen Peroxide results in increased expression of ADAM9 protein] | decreases reaction|increases expression | 17018608 17342749
|
D006861 |
Hydrogen Peroxide |
Cycloheximide inhibits the reaction [Hydrogen Peroxide results in increased expression of ADAM9 protein] | decreases reaction|increases expression | 17018608
|
D006861 |
Hydrogen Peroxide |
Dactinomycin inhibits the reaction [Hydrogen Peroxide results in increased expression of ADAM9 protein] | decreases reaction|increases expression | 17018608
|
D006861 |
Hydrogen Peroxide |
ebselen inhibits the reaction [Hydrogen Peroxide results in increased expression of ADAM9 protein] | decreases reaction|increases expression | 17018608
|
D006861 |
Hydrogen Peroxide |
Hydrogen Peroxide results in increased expression of ADAM9 protein | increases expression | 17342749 17018608
|
C025462 |
sulindac sulfide |
sulindac sulfide results in decreased expression of ADAM9 mRNA | decreases expression | 16184548
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of ADAM9 mRNA | affects expression | 14699072
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of ADAM9 mRNA | affects expression | 17555576
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ADAM9 mRNA | affects cotreatment|increases expression | 17942748
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.64 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.93 | 15322242 14514962 11752688 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.04 | 17505938 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
4.40 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
4.40 | 11473722 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
2.78 | 3712494 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.46 | 16835633 |
MESH:D000544 |
Alzheimer Disease |
|
sulindac sulfide |
3.10 | 18759972 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.00 | 11748828 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.54 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.69 | 15885639 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
5.12 | 11289319 1440618 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.10 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.89 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.80 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Dactinomycin |
5.63 | 14601052 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
1.86 | 16541309 17200150 16873071 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
1.86 | 18984771 19066611 18855134 20390343 20005174 19059307 19103187 17242785 18629630 19288272 18351453 17261762 16202921 21138602 20135344 16273361 11161223 19410462 19289846 20065188 19155303 18821012 19115204 18997820 18425577 17049068 19142967 19487384 20544844 16818667 19189210 19244106 15565566 16873071 15668708 17893378 19084267 19189212 19011961 19200415 18815881 21152245 17440819 20859285 19221464 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.86 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.84 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.58 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
6.65 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
6.65 | 7296757 3581430 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
6.65 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
6.65 | 16924424 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
sulindac sulfide |
3.46 | 12391285 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
2.70 | 7296757 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.66 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.39 | 18850075 16120746 18670907 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
7.65 | 16332659 |
MESH:D002318 |
Cardiovascular Diseases |
|
Hydrogen Peroxide |
7.65 | 16936243 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
6.78 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
6.78 | 7505956 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.21 | 16835633 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
7.99 | 9022650 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
7.99 | 16919318 17333356 17681005 17110522 16105132 15861022 11677210 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.12 | 8697196 16354765 15340226 15668235 12621046 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
2.29 | 17182828 |
OMIM:612775 |
CONE-ROD DYSTROPHY 9 |
marker/mechanism |
|
| |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.11 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 10048152 15322242 20055451 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.09 | 18551238 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.43 | 19031437 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.87 | 12868966 18759878 8156756 11298694 11906362 8970840 14531868 2524372 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.55 | 3621924 2952479 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
4.37 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.37 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
3.52 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
6.25 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
6.25 | 18692083 9328219 11289319 7440962 18648102 6679447 16192314 1440618 9653073 18289764 9022650 6482804 8291058 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.25 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.80 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.43 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.00 | 15322242 16714409 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
9.16 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
9.16 | 19031437 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
4.67 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
7.65 | 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
7.65 | 19155303 17893378 20544844 16202921 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.07 | 9294722 10568697 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
2.12 | 3581430 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.05 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
7.87 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
7.87 | 14986274 19224547 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.27 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.53 | 11858732 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
5.12 | 6705139 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.61 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.26 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.02 | 20067830 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
3.29 | 16598420 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
4.10 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.69 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.36 | 11294989 10048152 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.39 | 11000095 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
3.58 | 6705139 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.96 | 16120746 12621046 15340226 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.14 | 18606429 15340226 16354765 16959395 8697196 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
4.01 | 15034207 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.92 | 18670907 18850075 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.88 | 16569931 16945680 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.52 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.52 | 17937319 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
4.98 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
4.98 | 12878042 12200463 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
5.12 | 9022650 8074119 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.39 | 16580747 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Hydrogen Peroxide |
4.33 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
12.68 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
12.68 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
12.68 | 18625569 |
MESH:D007938 |
Leukemia |
|
Genistein |
3.05 | 18980019 17468513 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.19 | 15342952 17567588 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.23 | 9327722 15034207 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
3.51 | 17823541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
3.51 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.51 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
7.49 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
7.49 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.49 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
9.96 | 2876784 2876786 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
9.96 | 598648 3712494 1399818 6587162 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
9.96 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
2.26 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.26 | 19555203 11884234 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.84 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
6.22 | 12929590 14578162 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
6.22 | 19196723 19196722 16827153 11731420 14580682 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.64 | 19453300 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
1.89 | 19393235 12393984 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.26 | 15990972 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
2.88 | 17141266 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.06 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
3.70 | 17141266 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
3.94 | 18551238 7678174 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
5.76 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
5.76 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.53 | 19410462 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
4.10 | 19189210 19200415 19196722 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
9.82 | 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
9.82 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
2.95 | 6679447 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
9.05 | 16049721 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
9.05 | 4026338 6482804 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
5.12 | 3988306 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
3.28 | 19401787 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
4.14 | 16169203 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
2.61 | 19005980 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.75 | 11578682 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
9.56 | 7296757 |
MESH:D010212 |
Papilloma |
|
Hydrogen Peroxide |
9.56 | 12065085 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.35 | 12520081 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.57 | 6228378 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.62 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.27 | 11222880 11896295 11399792 11118676 |
MESH:D011471 |
Prostatic Neoplasms |
marker/mechanism |
|
| 17018608 |
MESH:D011471 |
Prostatic Neoplasms |
|
bicalutamide |
2.72 | 15638997 19011039 19240160 18487222 17914592 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
2.72 | 15378649 15256057 16925846 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.72 | 15067354 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.39 | 16919318 15861022 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.90 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.41 | 3692021 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Dactinomycin |
5.14 | 14601052 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
2.57 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
Hydrogen Peroxide |
5.81 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.81 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
11.89 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
11.89 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
4.12 | 19457130 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.68 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.20 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.00 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
2.92 | 1399818 7505956 6582329 3712494 6587162 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
8.40 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
8.40 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
8.40 | 17572228 8653321 16712894 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.40 | 10091137 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
9.91 | 14692618 |
MESH:D014594 |
Uterine Neoplasms |
|
sulindac sulfide |
9.91 | 18645019 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.69 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.59 | 14671159 15869587 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.35 | 15886252 |